Dinglong Xue
Overview
Explore the profile of Dinglong Xue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xue D, Li N, Yang J, Men K, Li L, Jiang H, et al.
Front Oncol
. 2024 Oct;
14:1450020.
PMID: 39376979
Introduction: Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of a number of patients with advanced cancer, and while this has resulted in increased survival times, it has also led...
2.
Li N, Xue D, Zhao X, Li L, Men K, Yang J, et al.
J Psychosom Res
. 2024 Aug;
186:111892.
PMID: 39197232
Background: Sleep disturbances are highly prevalent in oncology and often exacerbate symptoms, leading to reduced quality of life, which in turn may further affect the tolerability and efficacy of oncological...
3.
Li N, Xue D, Men K, Li L, Yang J, Jiang H, et al.
Support Care Cancer
. 2024 May;
32(6):358.
PMID: 38750262
Background: Cancer-associated malnutrition is highly prevalent in advanced lung cancer, and 50% of global cancer-related deaths are attributed to cancer-associated malnutrition. Platinum-containing chemotherapy is the standard treatment for advanced lung...
4.
Xue D, Li N, Li L, Huang Y, Men K, Meng Q, et al.
Support Care Cancer
. 2022 Oct;
30(11):9659-9665.
PMID: 36203065
Background: Depression is the most prevalent psychological issue among cancer patients and can seriously affect patients' life and disease prognosis and even lead to suicide. Sarcopenia is a manifestation of...
5.
Zhang S, He Y, Xuan Q, Ling X, Men K, Zhao X, et al.
Cancer Sci
. 2022 Mar;
113(6):1999-2007.
PMID: 35302694
Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases and has the highest mortality rate among all solid tumors. It is characterized by early metastasis, and...